genkwadaphnin has been researched along with Hepatocellular Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, W; Guo, L; Li, F; Qiu, X; Ren, Y; Song, S; Wu, J | 1 |
1 other study(ies) available for genkwadaphnin and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Proliferation; Cholesterol; Diterpenes; Humans; Liver Neoplasms; Membrane Microdomains; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Nerve Tissue Proteins; Oxidoreductases Acting on CH-CH Group Donors; Plant Extracts; Xenograft Model Antitumor Assays | 2020 |